Susquehanna International Group
CGEM icon

Susquehanna International Group’s Cullinan Oncology CGEM Stock Holding History

Susquehanna International Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.03M Sell
143,200
-63,200
-31% -$812K ﹤0.01% 6142
2025
Q4 		$2.14M Buy
206,400
+195,700
+1,829% +$1.77M ﹤0.01% 5521
2025
Q3 		$63.5K Buy
10,700
+100
+0.9% +$732 ﹤0.01% 11776
2025
Q2 		$79.8K Sell
10,600
-400
-4% -$3.21K ﹤0.01% 11909
2025
Q1 		$83.3K Sell
11,000
-8,500
-44% -$81.6K ﹤0.01% 11652
2024
Q4 		$238K Buy
19,500
+7,300
+60% +$105K ﹤0.01% 10334
2024
Q3 		$204K Sell
12,200
-30,900
-72% -$548K ﹤0.01% 10434
2024
Q2 		$752K Buy
+43,100
New +$918K ﹤0.01% 7252
2022
Q4 		– Sell
-12,400
Closed -$159K – 12512
2022
Q3 		$159K Buy
+12,400
New +$167K ﹤0.01% 11154

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Susquehanna International Group's CGEM Position: Q1 2026 in Review

Susquehanna International Group increased its Cullinan Oncology (CGEM) stake by 19% in Q1 2026, buying an estimated $97.1K and bringing the position to 47,377 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #8895.

Susquehanna International Group first reported a position in CGEM in Q4 2021 and has held it in 16 quarters since. The position peaked at $978K in Q2 2025. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Susquehanna International Group held 47,377 shares of Cullinan Oncology worth $673K as of Q1 2026.
  • Susquehanna International Group bought 7,555 Cullinan Oncology shares in Q1 2026, an estimated $97.1K.
  • Cullinan Oncology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8895 holding.
  • Susquehanna International Group first reported a position in Cullinan Oncology in Q4 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Cullinan Oncology position peaked at $978K in Q2 2025.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.